Hosp Pharm. 2015 May;50(5):386-90. doi: 10.1310/hpj5005-386.
Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses.
Hospital pharmacy
Sami Sakaan, Dagny Ulrich, Jenny Luo, Christopher K Finch, Timothy H Self
Affiliations
Affiliations
- Clinical Pharmacist, Methodist University Hospital , Memphis, Tennessee.
- University of Tennessee Health Science Center , Memphis.
- Assistant Director, Clinical Pharmacy Services, Methodist University Hospital , Memphis, Tennessee ; Associate Professor of Clinical Pharmacy, University of Tennessee Health Science Center , Memphis.
- Professor of Clinical Pharmacy, University of Tennessee Health Science Center , Memphis ; Program Director, PGY2 Internal Medicine Pharmacy Residency, Methodist University Hospital , Memphis, Tennessee.
PMID: 26405325
PMCID: PMC4567205 DOI: 10.1310/hpj5005-386
Abstract
BACKGROUND: Hospitalized patients with chronic obstructive pulmonary disease (COPD) or asthma routinely have inhaled medications ordered for acute and maintenance therapy. Treatment may be administered via metered-dose inhaler (MDI) or dry-powder inhaler (DPI). These products must be appropriately labeled to be released home with the patient or discarded before discharge.
OBJECTIVE: To assess the amount and estimated cost of wasted doses of medications via MDI or DPI for hospitalized patients with COPD/asthma.
METHODS: A retrospective study was conducted at a university-affiliated hospital. Patients admitted between January 2011 and June 2012 with a primary diagnosis of COPD or COPD with asthma and who were ≥40 years of age were included. Information collected included use of albuterol, ipratropium, inhaled corticosteroids, long-acting beta agonist, or tiotropium and whether treatments were given by nebulizer, MDI, MDI plus valved holding chamber (VHC), or DPI. The number of doses dispensed, as well as doses not used, via MDI, MDI + VHC, or DPI were collected from electronic medical records. Costs associated with wasted medications were evaluated.
RESULTS: Of 555 patient admissions screened, 478 (mean age, 66 years; 58% women; 74% African American) met study criteria. Of the total MDI or DPI doses dispensed, 87% were wasted, and associated hospital cost was approximately $86,973.
CONCLUSIONS: Substantial waste of inhaled medications was found in our study. Practical strategies are needed to reduce wasted inhalers. Further assessment of this problem is needed in other US hospitals.
Keywords: hospitalized COPD patients; inhalers; waste
References
- Chest. 1992 Feb;101(2):305-8 - PubMed
- Can J Clin Pharmacol. 2008 Summer;15(2):e334-43 - PubMed
- Chest. 1992 Mar;101(3):634-7 - PubMed
- Respir Med. 2008 Jul;102(7):993-8 - PubMed
- Arch Intern Med. 1989 Mar;149(3):618-23 - PubMed
- Arch Intern Med. 1996 Oct 14;156(18):2113-8 - PubMed
- Chest. 1989 Dec;96(6):1241-6 - PubMed
- Chest. 1987 Apr;91(4):614-8 - PubMed
- Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55 - PubMed
- Am J Health Syst Pharm. 2005 May 15;62(10):1053-61 - PubMed
- Chest. 2005 Jan;127(1):335-71 - PubMed
- Respir Care. 2008 Mar;53(3):338-45 - PubMed
- South Med J. 2011 Nov;104(11):742-5 - PubMed
Publication Types